CA
NZ
UK
AU
IND
US
Bristol Myers Squibb (NYSE: BMY) has vaulted to the front of the pharmaceutical industry’s AI adoption curve by signing a multi-year strategic agreement with Anthropic to deploy its Claude Enterprise platform across global workflows. The deal—unveiled on Wednesday—marks a decisive shift from fragmented, department-level …
UCB (Euronext Brussels: UCB) has deepened its claim on the psoriasis market after releasing detailed data from a head-to-head psoriatic-arthritis trial showing Bimzelx’s superiority over AbbVie’s (NYSE: ABBV) Skyrizi. In the study, 49% of patients treated with Bimzelx achieved a 75% reduction in disease-activity …
A federal jury in Philadelphia delivered a historic blow to Takeda Pharmaceutical Company Limited on May 21st, ordering the Japanese drugmaker to pay $885m for orchestrating what prosecutors described as an illegal “pay-for-delay” scheme around its constipation drug Amitiza—used by roughly 3m Americans annually. …
Key HighlightsPharmaMarketingis pivoting from broad campaigns to targeted, consent-based engagement—amid a 1.7m strong HCP audience (Fierce Pharma, 2026)Audio marketing—including podcasts—is gaining traction as a way to cut through information saturation for healthcare professionalsBrands are shifting from promotional messaging to partnerships built on trust, per …
Geopolitical Risk Drives the Rebound
A Plan Built on Scale, Not Simplicity
Peace Hopes Fade, Safe Haven Narrative Fractures
Pullback From Record Holds as Peace Optimism Fades
US natural gas futures steadied at $3.02 per MMBtu on Thursday, partially recovering from a 3.5% drop in the prior session. The rebound is modest and largely technical. The fundamental driver behind the earlier decline remains intact: the intense heat that had gripped the …
On 21 May 2026, META (NASDAQ:META) remains a focal point for US investors as Meta Platforms continues to occupy a central position among Big Tech leaders. Trading desks describe ongoing engagement with the stock as investors weigh AI-related investments, advertising trends and the company's …
Please wait processing your request...